Rapid Micro Biosystems (RPID) Capital Expenditures (2020 - 2026)

Rapid Micro Biosystems has disclosed Capital Expenditures across 7 years of filings, most recently posting $394000.0 for Q1 2026.

• Capital Expenditures for Q1 2026 came in at $394000.0, up 23.51% year-over-year; the trailing twelve-month figure through Mar 2026 was $925000.0 (down 15.83% YoY), and the FY2025 annual result was $850000.0, down 37.73% from the prior year.
• Capital Expenditures came in at $394000.0 for Q1 2026 at Rapid Micro Biosystems, down from $786000.0 in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $5.5 million in Q3 2022 to a low of -$5.4 million in Q4 2022.
• The 5-year median for Capital Expenditures is $319000.0 (2025), against an average of $212529.4.
• Peak annual rise in Capital Expenditures reached 498.8% in 2022, while the deepest fall reached 860.34% in 2022.
• Rapid Micro Biosystems' Capital Expenditures stood at -$5.4 million in 2022, then jumped by 104.45% to $239000.0 in 2023, then soared by 459.41% to $1.3 million in 2024, then plunged by 41.21% to $786000.0 in 2025, then sank by 49.87% to $394000.0 in 2026.
• The last three Capital Expenditures figures came in at $394000.0 (Q1 2026), $786000.0 (Q4 2025), and -$11000.0 (Q3 2025), per Business Quant data.